US$ 27.20
glp-1 advertising news April 2023 Recap: Behind the Headlines Ozempic, Wegovy, Ro: GLP-1 ads
Description
Here is a list of approved and pending new GLP-1 agonists class of medications that can help manage Type 2 diabetes and obesity.

Methods A comprehensive literature review was conducted, including evidence from case reports, randomized controlled trials, prospective cohorts, and experimental studies, to assess the role of GLP-1RAs in psoriasis treatment
Only 34% of GLP-1 on DPP-4 inhibitors were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy, according to our pharmacy claims data.

Credit: Joanna Sadowska, PhD, EMBA !

Freezer-safe and precision-fit because your protocol demands nothing less
